Stephen Cella

Stephen Cella is a healthcare-focused finance and private-equity professional. He earned a Bachelor of Arts in Economics from Northwestern University and a Master of Business Administration in Finance from The Wharton School of the University of Pennsylvania. He began his career at Wells Fargo Securities, serving as an Investment Banking Analyst in the Financial Sponsors Group and later as a Research Associate in the firm's Principal Investing Group, where he structured, executed, and invested in high-yield credit and corporate financings including leveraged buyouts, recapitalizations, and restructurings.

In 2012 Cella joined Sun Capital Partners, Inc. — the Boca Raton- and New York-based private-equity firm — as a Principal responsible for the firm's healthcare investments. There he concentrated on "consumer-oriented" healthcare specialties and business services, working alongside Managing Director Dan Florian on the firm's patient-centered investing approach and helping portfolio companies adopt retail/consumer operating best practices (for example, call-center and scheduling improvements at dental-implant provider ClearChoice).

Cella subsequently moved to LightBay Capital, a Los Angeles-based private-equity firm focused on healthcare and consumer businesses, where he served as a Principal — sourcing and analyzing new investments, building financial models, running due diligence and deal execution, and monitoring portfolio companies. This period reflects the "New York and California" investment-banking and principal-investing arc described in his current bio.

In 2024, Cella transitioned from the buy-side into an operating role, joining The Oncology Institute (NASDAQ: TOI) as Senior Vice President of Finance, where he oversees finance, accounting, and investor relations, bringing more than 15 years of corporate-finance experience — roughly a decade of it in healthcare — to support the company's oncology-care platform.

• Sector: Healthcare, with emphasis on consumer-oriented provider specialties (dental, dermatology, primary care) and healthcare business/managed-care services.
• Approach: A "patient-centered" investing philosophy — Sun Capital looked for businesses with a strong consumer mindset and used its operational resources to push retail/consumer best practices (scheduling, call-center productivity, appointment utilization) into portfolio companies.
• Stage & structure: Middle-market control buyouts and growth equity (Sun Capital / LightBay style), not early-stage seed or angel checks. No public evidence of angel or seed-stage activity.
• What made him say yes (inferred from his deals & statements): consumer-facing healthcare providers with multi-site/roll-up potential and clear operational-improvement levers.